Rosa Villa Sanz, the Scientific Director of NANBIOSIS U8 Micro– Nano Technology Unit was appointed group leader the CIBER during the last meeting of the Permanent Commission of CIBER-BBN, replacing Prof. Jordi Aguiló.
Rosa Villa Sanz, graduated in Medicine from the University of Barcelona and has a doctorate from the Autonomous University of Barcelona in 1993 and a specialist in Nuclear Medicine (MIR-Hospital de Bellvitge-Barcelona), is a scientific researcher at the CSIC and leader of the Biomedical Applications Group of the Barcelona Institute of Microelectronics (CSIC), whose main research interests are the design and manufacture of Micro and Nano Systems for Biomedical Applications.
Prof. Villa has participated in more than 30 national and European projects, being a principal researcher in 10 of them, she has obtained the approvals by the Spanish Agency of Medicines and Medical Devices (AEMPS) for the conduct of 4 clinical trials in collaboration with pharmaceutical companies and clinical groups and is the founder of a spin-off (Barcelona Liver Bioservice SL). Rosa Villa also directs a consolidated research group recognized by the Agència de Gestió d’Ajuts Universitaris i de Recerca since 2014 (Bio-Micro-Nano-Systems group [2019 SGR 988]) and since 2016 co-directs the BioMEM TECNIO group of the Generalitat de Catalunya. Rosa Villa is Scientific of NANBIOSIS Unit 8 since the creation of NANBIOSIS.